Does TAPENTADOL Cause Product distribution issue? 50 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Product distribution issue have been filed in association with TAPENTADOL (Nucynta). This represents 0.2% of all adverse event reports for TAPENTADOL.
50
Reports of Product distribution issue with TAPENTADOL
0.2%
of all TAPENTADOL reports
0
Deaths
3
Hospitalizations
How Dangerous Is Product distribution issue From TAPENTADOL?
Of the 50 reports, 3 (6.0%) required hospitalization.
Is Product distribution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAPENTADOL. However, 50 reports have been filed with the FAERS database.
What Other Side Effects Does TAPENTADOL Cause?
Death (11,560)
Toxicity to various agents (9,617)
Overdose (5,843)
Drug abuse (1,566)
Drug dependence (1,019)
Drug withdrawal syndrome neonatal (945)
Accidental overdose (693)
Drug ineffective (633)
Pain (436)
Nausea (434)
What Other Drugs Cause Product distribution issue?
LENALIDOMIDE (858)
CERTOLIZUMAB PEGOL (403)
SECUKINUMAB (340)
RUXOLITINIB (301)
HUMAN IMMUNOGLOBULIN G (279)
POMALIDOMIDE (254)
RELUGOLIX (243)
VEDOLIZUMAB (150)
PIMAVANSERIN (134)
TEDUGLUTIDE (132)
Which TAPENTADOL Alternatives Have Lower Product distribution issue Risk?
TAPENTADOL vs TAPINAROF
TAPENTADOL vs TARCEVA
TAPENTADOL vs TARLATAMAB
TAPENTADOL vs TARLATAMAB-DLLE
TAPENTADOL vs TASIGNA